Market Overview: The global leukemia therapeutics market was valued at USD 10.68 Billion in 2022 and is projected to reach USD 17.56 Billion by 2032, with a robust compound annual growth rate (CAGR) of 4.8% during the forecast period. The increasing prevalence of leukemia is a primary driver of market growth. Leukemia, a type of cancer affecting the bone marrow and blood, results in the...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian